|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/162 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61K 38/212 | (2013.01) | ||
| A61K 31/522 | (2013.01) | ||
| A61K 38/16 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| C07K 14/005 | (2006.01) | ||
| A61K 38/21 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61K 31/522 | (2006.01) | ||
| A61K 31/7072 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| C12N2730/10133 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 14/005 | (2013.01) | ||
| A61K 31/513 | (2006.01) | ||
| C12N2730/10122 | (2013.01) | ||
| A61K 31/7072 | (2006.01) | ||
| C12N2760/10122 | (2013.01) | ||
| A61P 31/14 | (2006.01) | ||
| C12N2760/10133 | (2013.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 31/513 | (2013.01) | ||
| A61P 31/20 | (2006.01) | ||
| A61P 31/20 | (2018.01) | ||
| A61P 31/14 | (2018.01) |
| (11) | Patento numeris | 3204030 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15775453.2 |
| Europos patento paraiškos padavimo data | 2015-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/073173 |
| Data | 2015-10-07 |
| (87) | Numeris | WO 2016/055534 |
| Data | 2016-04-14 |
| (30) | Numeris | Data | Šalis |
| 14187865 | 2014-10-07 | EP |
| (72) |
ALEXANDROV, Alexander , DE
|
| (73) |
Myr GmbH ,
Eiermarkt 3c, 30938 Burgwedel,
DE
|
| (54) | COMBINATION THERAPY OF HBV AND HDV INFECTION |
| COMBINATION THERAPY OF HBV AND HDV INFECTION |